Effects of Endocrine-Disrupting Chemicals on Bone Health

• Published in: Endocrinology and metabolism (Seoul) 2024, 39(4), , pp.539-551
• Main Authors: Park, So Young, Kong, Sung Hye, Kim, Kyoung Jin, Ahn, Seong Hee, Hong, Namki, Ha, Jeonghoon, Lee, Sihoon, Choi, Han Seok, Baek, Ki-Hyun, Kim, Jung-Eun, Kim, Sang Wan
• Format: Article
• Language: English
• Subjects: bone density; endocrine disruptors; osteoporosis; Review; 내과학
• ISSN: 2093-596X; 2093-5978; 2093-5978
• DOI: 10.3803/EnM.2024.1963

This comprehensive review critically examines the detrimental impacts of endocrine-disrupting chemicals (EDCs) on bone health, with a specific focus on substances such as bisphenol A (BPA), per- and polyfluoroalkyl substances (PFASs), phthalates, and dioxins. These EDCs, by interfering with the endocrine system's normal functioning, pose a significant risk to bone metabolism, potentially leading to a heightened susceptibility to bone-related disorders and diseases. Notably, BPA has been shown to inhibit the differentiation of osteoblasts and promote the apoptosis of osteoblasts, which results in altered bone turnover status. PFASs, known for their environmental persistence and ability to bioaccumulate in the human body, have been linked to an increased osteoporosis risk. Similarly, phthalates, which are widely used in the production of plastics, have been associated with adverse bone health outcomes, showing an inverse relationship between phthalate exposure and bone mineral density. Dioxins present a more complex picture, with research findings suggesting both potential benefits and adverse effects on bone structure and density, depending on factors such as the timing and level of exposure. This review underscores the urgent need for further research to better understand the specific pathways through which EDCs affect bone health and to develop targeted strategies for mitigating their potentially harmful impacts.